Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Glycobiology|December 6, 2012
Isolation of novel prototype galectins from the marine ball sponge Cinachyrella sp. guided by their modulatory activity on mammalian glutamate-gated ion channelsTakuya Ueda, Yuka Nakamura, Caleb M Smith, et al.Science Signaling|October 11, 2012
Interferon-induced SCYL2 limits release of HIV-1 by triggering PP2A-mediated dephosphorylation of the viral protein VpuKei Miyakawa, Tatsuya Sawasaki, Satoko Matsunaga, et al.Journal of Medical Case Reports|September 25, 2019
Aseptic meningitis caused by torque teno virus in an infant: a case reportYoji Ikuta, Kunihiro Oba, Emina Nai, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2013
Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levelsTomoaki Ishigami, Kaito Abe, Ichiro Aoki, et al.The Journal of Biological Chemistry|September 1, 2009
Paraquat toxicity induced by voltage-dependent anion channel 1 acts as an NADH-dependent oxidoreductaseHiroki Shimada, Kei-Ichi Hirai, Eriko Simamura, et al.Biochemical and Biophysical Research Communications|July 31, 2012
NMR study of xenotropic murine leukemia virus-related virus protease in a complex with amprenavirAyako Furukawa, Hideyasu Okamura, Ryo Morishita, et al.Oncotarget|May 29, 2018
Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptideKei Miyakawa, Satoko Matsunaga, Yutaro Yamaoka, et al.Nature Communications|January 31, 2017
The tumour suppressor APC promotes HIV-1 assembly via interaction with Gag precursor proteinKei Miyakawa, Mayuko Nishi, Satoko Matsunaga, et al.Nature Communications|January 28, 2022
Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteinsKei Miyakawa, Mayuko Nishi, Michinaga Ogawa, et al.Communications Medicine|March 31, 2026
Effectiveness, immunogenicity and safety of monovalent DS-5670a and bivalent DS-5670a/b SARS-CoV-2 vaccines: results from two randomized, active-comparator, non-inferiority trialsShunsuke Hamada, Miharu Suda, Katsuyasu Ishida, et al.Pageof 5